期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Toxicity of Selected Imidazolium-based Ionic Liquids on Caenorhabditis elegans: a Quantitative Structure-Activity Relationship Study 被引量:1
1
作者 卢丽亚 张颖捷 +1 位作者 陈洁洁 童中华 《Chinese Journal of Chemical Physics》 SCIE CAS CSCD 2017年第4期423-428,I0001,共7页
Due to the large number of ionic liquids (ILs) and their potential environmental risk, assessing the toxicity of ILs by ecotoxicological experiment only is insufficient. Quantitative structure- activity relationship... Due to the large number of ionic liquids (ILs) and their potential environmental risk, assessing the toxicity of ILs by ecotoxicological experiment only is insufficient. Quantitative structure- activity relationship (QSAR) has been proven to be a quick and effective method to estimate the viscosity, melting points, and even toxicity of ILs. In this work, the LC50 values of 30 imidazolium-based ILs were determined with Caenorhabditis elegans as a model animal. Four suitable molecular descriptors were selected on the basis of genetic function approximation algorithm to construct a QSAR model with an R^2 value of 0.938. The predicted lgLC50 in this work are in agreement with the experimental values, indicating that the model has good stability and predictive ability. Our study provides a valuable model to predict the potential toxicity of ILs with different sub-structures to the environment and human health. 展开更多
关键词 Imidazolium-based ionic liquids Caenorhabditis elegans TOXICITY Quantitative structure-activity relationship
下载PDF
Chronic Toxicity of a Novel Recombinant Human Granulocyte Colony-stimulating Factor in Rats 被引量:6
2
作者 Fei Xia Qing-yu Zhang Yong-ping Jiang 《Chinese Medical Sciences Journal》 CAS CSCD 2011年第1期20-27,共8页
Objective To assess the severity and reversibility of the chronic toxicity of a novel recombinant human granulocyte colony-stimulating factor (rhG-CSFa) in rats and the dose-effect relationship.Methods A total of 100 ... Objective To assess the severity and reversibility of the chronic toxicity of a novel recombinant human granulocyte colony-stimulating factor (rhG-CSFa) in rats and the dose-effect relationship.Methods A total of 100 Sprague-Dawley rats (equal numbers of male and female) were randomly divided into five groups (20 rats in each group):four groups were treated with rhG-CSFa at 500,100,10,1 μg/kg,respectively,and one group was treated with vehicle only to serve as the control.The rats were received subcutaneous injections of rhG-CSFa or vehicle daily for 13 weeks.During the course of the chronic toxicity study,the physical status,body weight,and food consumption were monitored.Half of the rats in each group (n=10) were sacrificed after the last rhG-CSFa administration,and the other half were sacrificed at five weeks after the last rhG-CSFa administration.Urinalyses,blood biochemistry,hematological analysis,histopathological examination,and immunological tests were performed for each of the rats.Results The hematological analyses revealed that the mean white blood cells count,neutrophils count,and neutrophils percentage were increased in male rats at the dose of 10 μg/kg or higher,and these were related with the biological activity of rhG-CSFa.Some small abnormalities were observed in the spleen of a few rats when used highest dose (500 μg/kg,a dosage of 200 folds higher than the normal clinical dosage),but these abnormalities were recovered within 5-week recovery period.No other rhG-CSFa-related abnormalities were observed in this chronic toxicity study.Conclusion No significant toxicity and immunogenicity are observed with rhG-CSFa administration to rats in the chronic toxicity studies. 展开更多
关键词 chronic toxicity Sprague-Dawley rat novel recombinant human granulocytecolony-stimulating factor
下载PDF
中药新药毒性与抗癌效应研究 被引量:6
3
作者 任小巧 高增平 穆丽莎 《中医学报》 CAS 2015年第1期7-9,共3页
开发有效、低毒的抗癌中药的有效途径为:1采取药效与毒性相结合的研究方法,比较研究原药材、毒性成分(组分)和去毒药材的抗癌效果,建立科学的存效脱毒(减毒)方法。2建立符合中医理论的"抗癌中药癌症毒理实验动物模型"来评价... 开发有效、低毒的抗癌中药的有效途径为:1采取药效与毒性相结合的研究方法,比较研究原药材、毒性成分(组分)和去毒药材的抗癌效果,建立科学的存效脱毒(减毒)方法。2建立符合中医理论的"抗癌中药癌症毒理实验动物模型"来评价抗癌中药的毒性。3以中医药理论为基础、以疗效为中心,确定抗癌新药的"效-毒"关系、建立与中医理论相适应的动物模型及多种靶点筛选模型,开展抗癌中药新药的疗效及机制研究。 展开更多
关键词 中药新药 (减) “抗癌中药癌症理学实验动物模型” “效-毒”关系
下载PDF
Design, synthesis and antitumor activity evaluation of novel 2,6-dichloro-3,5-dinitrotoluene derivatives
4
作者 Jiayuan Jiao Hao Hu +3 位作者 Siyuan Wei Wanqiu Wang He Lin Baoshan Chai 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2018年第3期159-169,共11页
A series of novel 2,6-dichloro-3,5-dinitrotoluene derivatives were designed, synthesized in the present study, and their antitumor activities against five cell lines(A431, HepG2, A549, HT-29 and HEK-293) were tested... A series of novel 2,6-dichloro-3,5-dinitrotoluene derivatives were designed, synthesized in the present study, and their antitumor activities against five cell lines(A431, HepG2, A549, HT-29 and HEK-293) were tested. Most of the compounds exhibited moderate-to-significant cytotoxicity and high selectivity against one or more cell lines in comparison with cisplatin. Studies on their preliminary structure-activity relationships(SARs) indicated that compounds containing phenyl(piperazin-1-yl) methanone groups, especially chlorine atom at 4-position of the phenyl ring, were more effective. Compound 4g was found to be the most potent derivative with IC_(50) values of 1.04, 3.20, 6.93, 4.10 and 20.15 μmol/L against A431, HepG2, A549, HT-29 and HEK-293 cell lines, respectively, which was better than positive control cisplatin, one of the most clinically used chemotherapeutic drugs. 展开更多
关键词 2 6-Dichloro-3 5-dinitrotoluene Cytotoxic activity Structure-activity relationships
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部